Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Aug 04, 2021 3:15pm
20 Views
Post# 33649384

RE:i do hope the bashers on bids are buying...

RE:i do hope the bashers on bids are buying...

There is a buyer for every seller. Here's how it works, kid.

The stock goes down from $20 to $2.85 when there are many, many large sellers compared to buyers. There is no evidence that stock is going either way right now but trend is definitely down with sell off of divisions and no indications to replace the top 2 4050/Fezagrapras indications planned phase 2 trials that they stopped pursuing. In well over 2 months, they have made no statements of what they would work on or if there is any further indications on Fezagrapras to pursue. Meanwhile, money is running out quickly and thomvest is not bridging money to them even with the voucher being worth $70M. So, what does that tell you about Thomvest/ management support? No demand here, all institutionals have lost huge here so why would you think that anyone would invest with these crooks? 

 

 

<< Previous
Bullboard Posts
Next >>